Filana Therapeutics, Inc. (FLNA)
NASDAQ · Healthcare
Filana Therapeutics, Inc. EBITDA 2009–2013
Filana Therapeutics, Inc. annual/quarterly ebitda history and growth rate from 2009 to 2012. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Filana Therapeutics, Inc. ebitda for the quarter ending March 31, 2012 was -113000, a 73.47% decrease year-over-year.
- Filana Therapeutics, Inc. annual ebitda for 2012 was -3.8 M, a 12.65% increase from 2011.
- Filana Therapeutics, Inc. annual ebitda for 2011 was -3.4 M, a 75.12% decrease from 2010.
- Filana Therapeutics, Inc. annual ebitda for 2010 was -13.5 M, a 107.34% increase from 2009.
- Filana Therapeutics, Inc. annual ebitda for 2009 was -6.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Filana Therapeutics, Inc. EBITDA — FAQ
Filana Therapeutics, Inc. (FLNA) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FLNA's ebitda history?
The chart and table above show Filana Therapeutics, Inc.'s ebitda by year and by quarter, including the growth rate.